Enhanced navigation shortens time until guideline-adherent, postoperative radiotherapy (PORT) among patients with head and neck squamous cell carcinoma (HNSCC) compared with standard navigation, according to a study.
The findings of the randomized controlled trial suggest that greater efforts are needed to develop and use enhanced, navigation-based approaches in this patient population, lead author Evan M. Graboyes, MD , of Medical University of South Carolina, Charleston, South Carolina, and colleagues, said.
“Initiation of PORT within 6 weeks of surgery is recommended by National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology and is the only Commission on Cancer-approved quality metric for HNSCC,” the investigators wrote in JCO Oncology Practice . “[